Emergency:
+91-124 4588 888
  • Download PHR App

Chronic Lymphocytic Leukemia (CLL) Treatment in Gurgaon, Haryana

Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that affects the white blood cells and can gradually impact immunity, energy levels, and overall quality of life. While early-stage CLL may be monitored or managed with targeted medications, advanced or progressive cases often require specialised treatment for better disease control. 

At Artemis Hospitals, Gurgaon, we provide comprehensive evaluation and advanced treatment for Chronic Lymphocytic Leukemia, including targeted therapy, immunotherapy, and precision-based care plans tailored to each patient. Early consultation and timely intervention can help manage symptoms effectively and improve long-term outcomes. 

Quick Facts About Chronic Lymphocytic Leukemia

Aspect

Details

Common Symptoms

Persistent fatigue, swollen lymph nodes, frequent infections, unexplained weight loss 

Primary Treatment

Targeted therapy, immunotherapy, chemotherapy, or stem cell transplant (in selected cases) 

Techniques Used

Precision-based targeted drugs, monoclonal antibodies, advanced hematology care 

Recovery

Varies depending on disease stage, treatment response, and overall patient health 

What is Chronic Lymphocytic Leukemia (CLL)?

Chronic Lymphocytic Leukemia (CLL) is a slow-growing blood cancer that affects your white blood cells, which are responsible for fighting infections. Over time, it can weaken your immune system, cause tiredness, swollen lymph nodes, and make you more prone to frequent infections. 

CLL is a type of cancer that originates in the bone marrow and leads to the uncontrolled proliferation and accumulation of abnormal B-lymphocytes in the blood, bone marrow, and lymphoid tissues. It is classified as a chronic lymphoproliferative disorder and typically progresses gradually over time. 

Symptoms of Chronic Lymphocytic Leukemia

In the early stages, CLL symptoms may not be noticeable and are often detected during routine blood tests. When present, early signs may include: 

  • Persistent fatigue or low energy 
  • Mild, painless swelling of lymph nodes (neck, armpit, groin) 
  • Frequent or prolonged infections 
  • Mild unexplained weight loss 
  • Occasional night sweats 

As the disease progresses, symptoms may become more pronounced and affect daily functioning: 

  • Significant enlargement of lymph nodes 
  • Enlarged spleen or liver causing abdominal fullness or discomfort 
  • Unexplained fever and drenching night sweats 
  • Rapid weight loss 
  • Easy bruising or bleeding 
  • Severe anemia leading to breathlessness and extreme fatigue 

While surgery is not a routine treatment for CLL, certain complications may require procedural or surgical evaluation: 

  • Massive spleen enlargement causing persistent pain or pressure symptoms 
  • Severely enlarged lymph nodes compressing nearby organs or structures 
  • Recurrent infections not responding to medical management 
  • Significant bleeding or bone marrow failure complications 

These symptoms typically signal disease progression or complications that require urgent specialist assessment and advanced treatment planning. 

Causes of Chronic Lymphocytic Leukemia (CLL)

The exact cause of Chronic Lymphocytic Leukemia is not fully understood. It develops due to genetic changes in certain white blood cells (B-lymphocytes), leading to their uncontrolled growth. While a direct cause is often unclear, several contributing factors are grouped below: 

Lifestyle-Related Factors

CLL is not strongly linked to lifestyle habits, but certain exposures may increase risk: 

  • Long-term exposure to toxic chemicals such as pesticides or industrial solvents 
  • Possible environmental toxin exposure over time 
  • Smoking (indirectly linked to overall blood cancer risk) 

Medical Conditions

Some medical and biological factors may contribute: 

  • Pre-existing immune system disorders 
  • History of other blood disorders 
  • Previous cancer treatments involving chemotherapy or radiation (rarely associated) 

Congenital / Age-Related Factors

These are among the most significant contributors: 

  • Increasing age (most common in individuals over 60 years) 
  • Family history of CLL or other lymphoid cancers 
  • Genetic mutations acquired over time in bone marrow cells 

Risk Factors for Chronic Lymphocytic Leukemia

Certain factors increase the likelihood of developing CLL: 

  • Male gender 
  • Advancing age 
  • Exposure to certain herbicides or chemicals 
  • Caucasian ethnicity (higher incidence reported) 

It’s important to note that many individuals with these risk factors may never develop CLL, while some diagnosed patients may not have any identifiable risk factors. 

Types of Chronic Lymphocytic Leukemia

CLL does not behave the same way in every patient. In some people, it progresses very slowly over years. In others, it may advance more quickly and require earlier treatment. Based on behaviour and genetic profile, CLL can be broadly understood as follows: 

1. Indolent (Slow-Growing) CLL

This is the most common type. 

In indolent CLL: 

  • The disease progresses very slowly 
  • Patients may remain stable for years without needing treatment 
  • Symptoms are mild or absent in early stages 
  • Watchful waiting (active surveillance) is often recommended 

Many individuals with this type live long, active lives with careful monitoring and timely intervention only when necessary. 

2. Aggressive CLL

In this form, the disease progresses more rapidly. 

It may show: 

  • Rapid increase in lymphocyte count 
  • Enlarging lymph nodes or spleen 
  • Significant fatigue, weight loss, or infections 
  • Falling hemoglobin or platelet levels 

Aggressive CLL usually requires earlier and more intensive treatment. Close monitoring is essential to prevent complications. 

3. CLL with High-Risk Genetic Mutations (del17p, TP53)

Some patients have specific genetic abnormalities in their leukemia cells, such as: 

  • Deletion 17p (del17p)
  • TP53 gene mutation

These mutations are associated with: 

  • Poorer response to conventional chemotherapy 
  • Higher risk of disease progression 
  • Need for targeted therapy instead of standard chemo 

Identifying these mutations through molecular testing is crucial because they directly influence treatment decisions and long-term prognosis. 

When to Consult the Doctor for Chronic Lymphocytic Leukemia Treatment?

CLL often progresses slowly, and in early stages, you may not even notice symptoms. But when signs become persistent, worsening, or start interfering with daily life, it’s important not to ignore them. 

You should consult a doctor if you experience: 

  • Extreme or worsening fatigue that doesn’t improve with rest 
  • Rapidly enlarging lymph nodes in the neck, armpits, or groin 
  • Persistent fever or drenching night sweats without infection 
  • Unexplained weight loss 
  • Frequent or severe infections 
  • Abdominal fullness or pain due to an enlarged spleen 
  • Easy bruising or unusual bleeding 

These signs may indicate that the disease is progressing or affecting blood cell production. If symptoms feel “out of control,” more intense, or visibly affecting your strength and immunity, it is time for medical evaluation. 

Persistent Fatigue, Recurrent Infections, or Swollen Lymph Nodes?
Get expert evaluation for suspected or confirmed CLL today.

Early consultation allows doctors to assess whether active treatment should begin, adjust current therapy, or manage complications before they become serious. Timely care can significantly improve disease control and overall quality of life. 

Diagnostic Tests for Chronic Lymphocytic Leukemia

Together, these tests confirm the diagnosis, determine disease stage, identify risk factors, and help doctors choose the most appropriate treatment plan. Here’s when each test is recommended — and what doctors look for if CLL is present. 

1. Complete Blood Count (CBC) and Peripheral Smear

Usually the first test. It may be done during routine health check-ups or when someone has symptoms like fatigue, infections, or swollen lymph nodes. 

  • Increased lymphocyte count (lymphocytosis) 
  • Possible anemia (low red blood cells) 
  • Low platelet count in advanced stages 
  • Peripheral smear may show small, mature-looking lymphocytes and characteristic “smudge cells” 

This test often raises the first suspicion of CLL. 

2. Flow Cytometry for Immunophenotyping

If CBC shows persistently high lymphocyte levels, this test is done to confirm whether the abnormal cells are CLL cells. 

  • Identifies abnormal B-lymphocytes 
  • Detects specific surface markers (such as CD5, CD19, CD23) typical of CLL 
  • Confirms the diagnosis and distinguishes CLL from other leukemias or lymphomas 

This is the key confirmatory test for CLL. 

3. Bone Marrow Biopsy (If Required)

Not always required for diagnosis. It may be done: 

  • To evaluate treatment response 
  • Suppression of normal blood cell production in advanced disease 

It helps assess disease burden and severity. 

4. Cytogenetic and Molecular Testing

After diagnosis, before deciding on treatment. These tests help determine prognosis and guide therapy selection. 

  • Chromosomal abnormalities (e.g., deletion 13q, 11q, 17p) 
  • TP53 mutation status 
  • IGHV mutation status 

Certain genetic changes (like 17p deletion or TP53 mutation) indicate more aggressive disease and influence treatment choice. 

5. Imaging Tests (CT / PET Scans)

  • If there are enlarged lymph nodes 
  • To assess spleen or liver enlargement 
  • When symptoms suggest disease progression 
  • Before certain treatments 

What do they find in CLL? 

  • Enlarged lymph nodes in chest, abdomen, or pelvis 
  • Enlarged spleen (splenomegaly) 
  • Extent of internal disease involvement 

PET scans are not routinely used but may be considered if transformation to a more aggressive lymphoma is suspected. 

Chronic Lymphocytic Leukemia Treatment at Artemis Hospitals, Gurgaon

At Artemis Hospitals, treatment planning is personalized based on disease stage, genetic testing results, patient age, and overall health — ensuring balanced, safe, and evidence-based care. 

1. Watchful Waiting (Active Surveillance)

In early-stage CLL, many patients do not need immediate treatment. 

Instead of starting medicines right away, doctors closely monitor the condition through: 

  • Regular blood tests 
  • Physical examinations 
  • Monitoring lymph node size 
  • Tracking symptoms 

If the disease is stable and not causing problems, treatment can safely be delayed. This avoids unnecessary side effects while keeping a close watch on disease progression. Treatment begins only if the CLL shows signs of worsening. 

2. Targeted Therapy & Immunotherapy

These are modern, precision-based treatments and are commonly used in CLL today. 

Targeted therapy works by blocking specific proteins or pathways that help leukemia cells grow and survive. Unlike traditional chemotherapy, it focuses more specifically on cancer cells. These include oral as well as IV medications, prescribed as per the patient's condition.

Immunotherapy helps the body’s immune system recognize and destroy leukemia cells. This often includes monoclonal antibodies that attach to abnormal B-cells and mark them for destruction. 

3. Chemotherapy-Based Regimens

Chemotherapy uses anti-cancer drugs to destroy rapidly dividing leukemia cells. 

In CLL, chemotherapy may be used: 

  • When targeted therapy is not suitable 
  • In selected high-burden disease cases 

It can be given orally or intravenously in cycles. While effective, chemotherapy may cause side effects such as fatigue, lowered immunity, hair thinning, or nausea — which are carefully managed by the oncology team. 

4. Stem Cell Transplantation

This is not a routine treatment for CLL and is considered only in the transformation of a cell into an aggressive form of B-cell lymphoma. 

In this procedure, diseased bone marrow cells are replaced with healthy stem cells (usually from a donor). It offers the possibility of long-term disease control but carries higher risks and requires careful patient selection and monitoring. 

5. Supportive and Infection-Prevention Care

Since CLL affects the immune system, supportive care is a crucial part of treatment. 

This includes: 

  • Preventive antibiotics (when needed) 
  • Immunoglobulin infusion 
  • Vaccinations (as medically appropriate) 
  • Blood transfusions for severe anemia 
  • Treatment for low platelet counts 
  • Management of treatment side effects 

The goal is to prevent complications, reduce infection risk, maintain strength, and improve overall quality of life throughout treatment. 

Recovery & Post-Treatment Care for Chronic Lymphocytic Leukemia

Recovery after CLL treatment is just as critical as the treatment itself. At Artemis Hospital, we ensure every patient is not just treated — but truly cared for, with a structured recovery plan designed for lasting wellness. 

Do's

Don'ts

Eat a balanced, nutrient-rich diet

Avoid raw/undercooked food 

Drink plenty of water 

Avoid alcohol and sugary beverages 

Engage in light walks and gentle exercises

Avoid strenuous workouts

Take all prescribed medications on time 

Never skip or self-discontinue any medication 

Regular follow-ups as advised by the hemat-oncologist to monitor disease progression and intervene timely. 

Don't ignore symptoms

Practice meditation and deep breathing 

Don't isolate or be in negative environments 

Maintain personal hygiene 

Avoid crowded places during

Use SPF protection if stepping outdoors 

Don't get direct sun exposure 

Why Choose Artemis Hospitals for Chronic Lymphocytic Leukemia Treatment in Gurgaon?

When it comes to battling Chronic Lymphocytic Leukemia, choosing the right hospital can change everything. Artemis Hospitals in Gurgaon offer cutting-edge medical advancement with deeply compassionate care. 

Our state-of-the-art oncology infrastructure is equipped with the latest diagnostic tools, targeted therapies, and immunotherapy protocols specifically designed to tackle CLL at every stage. 

At the heart of Artemis is our expert multidisciplinary team — seasoned hematologists, oncologists, and specialists who collaborate to plan the treatment as per the patient's unique condition. 

But beyond medicine, we believe healing is holistic. Our patient-first philosophy means every individual — and their loved ones — is welcomed into a warm, supportive environment. From dedicated patient counselors and stress-free appointment processes to comfortable facilities for visitors, we ensure the experience is as reassuring as the treatment itself. 

At Artemis Hospital, you're not just a patient — you're family. Trust us to walk alongside you through every step of your recovery with expertise, empathy, and unwavering dedication. 

Book an Appointment for Chronic Lymphocytic Leukemia Treatment in Gurgaon

If you or a loved one is seeking expert care for Chronic Lymphocytic Leukemia (CLL) in Gurgaon, Artemis Hospitals is your trusted destination. With world-class oncologists, advanced treatment protocols, and compassionate patient care, Artemis ensures you're in the best hands. Booking your consultation is simple — fill out our quick online form, call us at +91 98004 00498, or simply walk in to schedule an appointment at your convenience, subject to availability. Don't delay — early consultation can make all the difference. Your health journey begins at Artemis. 

Reviewed by Dr. Sukriti Gupta
Sr. Consultant
Artemis Hospitals

Frequently Asked Questions

How long can you live with chronic lymphocytic leukemia?

Studies show a 5-year relative survival rate of approximately 87–92%, with many patients living 10 to 20+ years depending on their specific risk profile. Timelines vary based on genetic markers (e.g., IGHV mutation), age, and disease stage, with some having a near-normal lifespan while aggressive forms may progress within 1–3 years.

CLL isn't directly inherited, but having a first-degree relative with it increases your risk significantly due to shared genetic predispositions.

Yes, CLL can return after a period of remission. Since CLL is generally a chronic condition, it may remain under control for years and then show signs of progression again. Regular follow-ups and blood tests help detect recurrence early so treatment can be restarted promptly if needed.

Patients should focus on infection prevention and overall health. This includes: 

  • Avoiding crowded places during low immunity 
  • Practicing good hand hygiene 
  • Staying up to date with doctor-recommended vaccinations 
  • Eating a balanced diet 
  • Reporting fever, unusual bleeding, or fatigue immediately 
  • Close monitoring and timely reporting of symptoms are very important. 

The duration varies. Some patients may require treatment for a fixed number of cycles, while others may take long-term targeted therapy for months or years. In early-stage cases under active surveillance, treatment may not be needed for a long time.

Yes. CLL treatment is available at advanced oncology centers with hematology specialists. In Gurgaon, comprehensive diagnostic and treatment facilities are accessible at tertiary-care hospitals.

Artemis Hospitals is one of the leading multi-specialty hospitals in Gurgaon offering advanced hematology and oncology care. The hospital provides comprehensive CLL management, including diagnostic testing, targeted therapy, immunotherapy, and supportive care under experienced blood cancer specialists.

The cost depends on several factors such as stage of disease, type of treatment (targeted therapy, chemotherapy, transplant), duration of therapy, hospital stay, and supportive care needs. Since treatment plans are individualized, a detailed evaluation is required for an accurate estimate.

Artemis Hospitals house the best cancer doctors in India. With years of expertise in cancer treatment plans, they provide a holistic plan for the patients depending on their condition.

Yes. Artemis Hospitals offers second opinion consultations for blood cancer. Patients can share previous reports, biopsy results, and treatment history for expert review, helping them make informed decisions about their care plan.

Health Insights : Blogs

View All Blogs

World Of Artemis

Artemis Hospitals, established in 2007, is a healthcare venture launched by the promoters of the 4$ Billion Apollo Tyres Group. It is spread across a total area of 525,000 square feet.

To know more
For any inquiries, appointment bookings, or general concerns, reach us at contactus@artemishospitals.com.
For International Patient Services, reach us at internationaldesk@artemishospitals.com.
For any feedback-related issues, reach us at feedback@artemishospitals.com.

Request a call back


Get Direction